Skip to content

Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy

Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy- A Pragmatic Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01727362
Enrollment
140
Registered
2012-11-16
Start date
2012-10-31
Completion date
2016-12-31
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, Acupuncture, Quality of Life

Brief summary

The aim of this trial is to investigate the effectiveness of acupuncture on quality of life in patients with breast cancer receiving chemotherapy compared to routine care.

Detailed description

At the Mammazentrum Hamburg, Germany, patients with breast cancer receiving chemotherapy have the opportunity to get acupuncture in addition to conventional therapy to maintain quality of life and to reduce the side effects of the chemotherapy such as gastrointestinal disorders. In this randomized trial we aim to investigate the effectiveness of additional acupuncture compared to routine care in patients with breast cancer.

Interventions

Patients of this group receive a semi-standardized acupuncture treatment over 6 month in addition to usual care

OTHERUsual care

Patients of this group receive usual care only

Sponsors

Mammazentrum Hamburg am Krankenhaus Jerusalem, Germany
CollaboratorUNKNOWN
Prof. Otto Beisheim Foundation
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed breast cancer (invasive, intraductal, hormone-sensitive and not hormone-sensitive, only locoregional metastases) * current chemotherapy at Mammazentrum Hamburg with regimen FEC/DOC or EC/DOC * willingness to receive acupuncture within the next 6 month if randomized in acupuncture group * willingness to refrain from acupuncture within the next 6 month if randomized in control group * informed consent

Exclusion criteria

* distant metastases * blood coagulation disorder and/or current use of anticoagulants * serious acute or chronic mental or physical disorders * clinically relevant cardiac arrhythmia symptoms * insufficient German language ability

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)6 month

Secondary

MeasureTime frame
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)3 month

Other

MeasureTime frameDescription
Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)3 month
Pain, quality of sleep, and nausea (single items of the FACT-B)3 month
Functional Assessment of Chronic Illness Therapy-Fatigue3 month
FACT/GOG-NTX, polyneuropathy symptoms3 month
Quality of Life (SF-12 Health Survey)3 month
Survival without relapse6 month
Survival6 month
Adverse effects and Interactions3 month
Satisfaction and patient-reported effectiveness3 monthThis will only be assessed in the acupuncture arm
Goal Attainment Scale3 monthThis will only be assessed in the acupuncture arm
Laboratory parameters (hemoglobin, leukocytes, blood plates, liver values, kidney values)3 month
Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being3 month

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026